Malaria Chemoprevention for the post-discharge management of severe anaemia in children in Malawi, Uganda and Kenya: Moving towards policy

Objectives

This project will look at whether routine treatment with malaria medicine through the first three months after discharge can be done in a safe and effective way. The research team will investigate this through a study in Kenya and Uganda, where children are randomized to receive three doses of the malaria medicine dihydroartemisinin-piperaquine, or three doses of placebo (oral medicine). The project will also investigate how such pre-construction can be made available in a good way. In Malawi, they will compare five ways to offer treatment to children after they are discharged from the hospital.